Unit
- Definition and Scope: Genetic testing analyzes DNA, RNA, or chromosomes to detect alterations linked to inherited disorders, predispositions, or pharmacogenetic responses. It encompasses diagnostic, predictive, carrier, and prenatal tests.
- Clinical Utility: Results guide medical management, including screening, diagnosis, prognosis, and treatment selection. For example, BRCA testing informs cancer risk reduction strategies.
- Test Types: Cytogenetic tests examine whole chromosomes; molecular tests focus on gene sequences; biochemical tests measure protein products. Each type has specific indications and limitations.
- Inheritance Patterns: Understanding autosomal dominant, recessive, X-linked, and mitochondrial inheritance is essential for interpreting familial risk and counseling patients.
- Accuracy and Validity: Analytical validity measures how accurately a test detects a variant; clinical validity assesses association with a condition. Both are critical for test selection.
- Limitations: Genetic tests may identify variants of uncertain significance (VUS), require confirmatory testing, and cannot predict all disease manifestations due to modifier genes and environment.
- Ethical Foundation: Principles of autonomy, beneficence, non-maleficence, and justice underpin genetic testing. Informed consent, privacy, and equity are core concerns.
- Professional Roles: Genetic counselors, medical geneticists, laboratory directors, and healthcare administrators each have distinct responsibilities in the testing pathway.
- Pretest Counseling: Informed consent involves discussing benefits, risks, limitations, and potential outcomes of testing. Patients must understand implications for family members, privacy protections, and the possibility of incidental findings before proceeding with any genetic test.
- Posttest Follow-up: After results are returned, appropriate management includes referral to specialists, cascade testing for at-risk relatives, and periodic reassessment as new evidence emerges. Patients should receive clear guidance on next steps and support resources.
- Regulatory Landscape: Genetic testing laboratories must comply with CLIA certification and, for some tests, FDA oversight. State laws may impose additional requirements regarding consent, data privacy, and reporting of genetic information to health departments or insurers.
- Reimbursement and Access: Coverage decisions vary by payer and test. Prior authorization often requires evidence of medical necessity. Program managers must navigate coding (CPT, ICD-10), negotiate contracts, and address disparities in access to testing for underserved populations.
- Quality Improvement: Continuous monitoring of test utilization, turnaround times, error rates, and patient satisfaction is essential. Implementing a quality management system with periodic audits and competency assessments ensures reliable and safe genetic testing services.
Scope of Practice
Role: Genetic Testing Program Manager
Within scope:
- Developing policies for test ordering and result disclosure
- Coordinating with laboratory and clinical teams for workflow integration
- Ensuring compliance with CLIA and HIPAA regulations
- Training staff on ethical and legal aspects of genetic testing
- Monitoring quality metrics and outcomes
Outside scope:
- Interpreting genetic test results for patients
- Providing genetic counseling without proper certification
- Directing clinical care decisions independently
- Modifying test methodologies or validating new assays
- Authorizing insurance coverage for tests
Quick Revision
- Genetic testing encompasses various types including diagnostic, predictive, carrier, and prenatal tests, each with specific clinical utility.
- Understanding inheritance patterns and test validity (analytical and clinical) is essential for appropriate test selection.
- Ethical principles guide the responsible use of genetic information, with distinct professional roles ensuring safe implementation.